|
🐜
|
Effector memory T cells, early metastasis, and survival in colorectal cancer.
16 auth.
F. Pagès,
A. Berger,
M. Camus,
F. Sánchez-Cabo,
A. Costes,
Robert Molidor,
B. Mlecnik,
A. Kirilovsky,
M. Nilsson,
D. Damotte,
...
T. Méatchi,
P. Bruneval,
P. Cugnenc,
Z. Trajanoski,
W. Fridman,
J. Galon
|
11 |
2005 |
11
🐜
|
|
🐜
|
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
8 auth.
Hanna Grauers Wiktorin,
M. Nilsson,
R. Kiffin,
F. E. Sander,
Brianna Lenox,
Anna Rydström,
...
K. Hellstrand,
A. Martner
|
6 |
2018 |
6
🐜
|
|
🐜
|
JAK–STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma
12 auth.
S. Dolatabadi,
Emma Jonasson,
M. Lindén,
B. Fereydouni,
Karin Bäcksten,
M. Nilsson,
...
A. Martner,
Amin Forootan,
H. Fagman,
G. Landberg,
P. Åman,
A. Ståhlberg
|
5 |
2019 |
5
🐜
|
|
🐜
|
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
14 auth.
F. E. Sander,
M. Nilsson,
Anna Rydström,
J. Aurelius,
Rebecca Riise,
C. Movitz,
Elin Bernson,
R. Kiffin,
A. Ståhlberg,
M. Brune,
...
R. Foà,
K. Hellstrand,
F. Thorén,
A. Martner
|
5 |
2017 |
5
🐜
|
|
🐜
|
IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections
10 auth.
B. Rugwizangoga,
Maria E. Andersson,
Jean-Claude Kabayiza,
M. Nilsson,
B. Ármannsdóttir,
J. Aurelius,
...
S. Nilsson,
K. Hellstrand,
M. Lindh,
A. Martner
|
4 |
2019 |
4
🐜
|
|
🐜
|
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity
20 auth.
S. Einarsdottir,
A. Martner,
J. Waldenström,
Malin Nicklasson,
Johan Ringlander,
M. Arabpour,
Andreas Törnell,
Hanna Grauers Wiktorin,
S. Nilsson,
Rudy Bittar,
...
M. Nilsson,
M. Lisak,
M. Veje,
V. Friman,
S. Al-Dury,
T. Bergström,
P. Ljungman,
M. Brune,
K. Hellstrand,
M. Lagging
|
4 |
2022 |
4
🐜
|
|
🐜
|
Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2
11 auth.
R. Kiffin,
Hanna Grauers Wiktorin,
M. Nilsson,
J. Aurelius,
Ebru Aydın,
Brianna Lenox,
...
J. Nilsson,
A. Ståhlberg,
F. Thorén,
K. Hellstrand,
A. Martner
|
4 |
2018 |
4
🐜
|
|
🦁
|
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
7 auth.
M. Nilsson,
Alexander Hallner,
M. Brune,
S. Nilsson,
F. Thorén,
A. Martner,
...
K. Hellstrand
|
3 |
2019 |
3
🦁
|
|
🐜
|
Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
14 auth.
Elin Bernson,
Alexander Hallner,
F. E. Sander,
Malin Nicklasson,
M. Nilsson,
K. Christenson,
Ebru Aydın,
J. Liljeqvist,
M. Brune,
R. Foà,
...
J. Aurelius,
A. Martner,
K. Hellstrand,
F. Thorén
|
3 |
2018 |
3
🐜
|
|
🦁
|
Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia
7 auth.
M. Nilsson,
Alexander Hallner,
M. Brune,
S. Nilsson,
F. Thorén,
A. Martner,
...
K. Hellstrand
|
3 |
2019 |
3
🦁
|
|
🐜
|
Incidence, detection and outcome of differentiated thyroid cancer in Western Sweden
8 auth.
J. Dahlberg,
C. Adok,
P. Bümming,
A. Demir,
G. Hedbäck,
B. Nilsson,
...
M. Nilsson,
S. Jansson
|
3 |
2021 |
3
🐜
|
